Kerntke Otto McGlone Wealth Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-7,387
Closed -$213K – 73
2023
Q4
$213K Sell
7,387
-573
-7% -$17.3K 0.21% 61
2023
Q3
$264K Sell
7,960
-265
-3% -$9.37K 0.27% 51
2023
Q2
$302K Buy
8,225
+1,048
+15% +$40.8K 0.3% 50
2023
Q1
$293K Buy
7,177
+19
+0.3% +$821 0.3% 49
2022
Q4
$367K Buy
7,158
+34
+0.5% +$1.63K 0.42% 41
2022
Q3
$312K Sell
7,124
-208
-3% -$10.1K 0.47% 40
2022
Q2
$384K Buy
7,332
+2,498
+52% +$127K 0.57% 32
2022
Q1
$250K Sell
4,834
-2,671
-36% -$139K 0.57% 28
2021
Q4
$443K Buy
7,505
+2,463
+49% +$122K 0.54% 34
2021
Q3
$217K Sell
5,042
-5,404
-52% -$239K 0.65% 34
2021
Q2
$409K Sell
10,446
-597
-5% -$23.2K 0.16% 91
2021
Q1
$400K Sell
11,043
-694
-6% -$24.6K 0.21% 91
2020
Q4
$432K Buy
11,737
+2,524
+27% +$92.6K 0.26% 78
2020
Q3
$321K Buy
9,213
+549
+6% +$19.2K 0.24% 78
2020
Q2
$269K Sell
8,664
-70
-0.8% -$2.38K 0.25% 79
2020
Q1
$270K Buy
8,734
+70
+0.8% +$2.38K 0.3% 63
2019
Q4
$322K Buy
+8,664
New +$309K 0.27% 74

Other funds holding PFE

Kerntke Otto McGlone Wealth Management Group's PFE Position: Q1 2024 in Review

Kerntke Otto McGlone Wealth Management Group sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,387 shares — an estimated $213K sold.

Kerntke Otto McGlone Wealth Management Group first reported a position in PFE in Q4 2019 and held it in 17 quarters. The position peaked at $443K in Q4 2021. 2,883 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Kerntke Otto McGlone Wealth Management Group reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Kerntke Otto McGlone Wealth Management Group sold 7,387 Pfizer shares in Q1 2024, an estimated $213K.
  • Kerntke Otto McGlone Wealth Management Group first reported a position in Pfizer in Q4 2019 and held it in 17 quarters.
  • Kerntke Otto McGlone Wealth Management Group's Pfizer position peaked at $443K in Q4 2021.
  • 2,883 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Kerntke Otto McGlone Wealth Management Group's 13F filing for Q1 2024, filed 10 May 2024.